These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16242260)

  • 1. A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer.
    Jin J; Li YX; Liu YP; Wang WH; Song YW; Li T; Li N; Yu ZH; Liu XF
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):725-9. PubMed ID: 16242260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].
    Jin J; Li YX; Liu YP; Wang WH; Li T; Li N; Song YW
    Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):393-6. PubMed ID: 17045010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial).
    Veerasarn V; Phromratanapongse P; Lorvidhaya V; Lertsanguansinchai P; Lertbutsayanukul C; Panichevaluk A; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Rojanasakul A; Thavichaigarn P; Jivapaisarnpong P
    J Med Assoc Thai; 2006 Nov; 89(11):1874-84. PubMed ID: 17205868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase I study of weekly intravenous oxaliplatin in combination with oral daily capecitabine and radiation therapy in the neoadjuvant treatment of rectal adenocarcinoma.
    Fakih MG; Rajput A; Yang GY; Pendyala L; Toth K; Smith JL; Lawrence DD; Rustum YM
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1462-70. PubMed ID: 16750332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer.
    Dunst J; Reese T; Sutter T; Zühlke H; Hinke A; Kölling-Schlebusch K; Frings S
    J Clin Oncol; 2002 Oct; 20(19):3983-91. PubMed ID: 12351595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of oxaliplatin in combination with capecitabine and radiotherapy as postoperative treatment for stage II and III rectal cancer.
    Jin J; Li YX; Wang JW; Wang WH; Liu YP; Wang K; Fang H; Zhou ZX; Zhou AP; Yu ZH
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):671-7. PubMed ID: 18455328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer.
    Rödel C; Arnold D; Hipp M; Liersch T; Dellas K; Iesalnieks I; Hermann RM; Lordick F; Hinke A; Hohenberger W; Sauer R
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1081-6. PubMed ID: 17881150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
    Rödel C; Liersch T; Hermann RM; Arnold D; Reese T; Hipp M; Fürst A; Schwella N; Bieker M; Hellmich G; Ewald H; Haier J; Lordick F; Flentje M; Sülberg H; Hohenberger W; Sauer R
    J Clin Oncol; 2007 Jan; 25(1):110-7. PubMed ID: 17194912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
    Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
    Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer.
    Parulekar W; de Marsh RW; Wong R; Mendenhall W; Davey P; Zlotecki R; Berry S; Rout WR; Bjarnason GA
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1487-95. PubMed ID: 15050328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
    Freedman GM; Meropol NJ; Sigurdson ER; Hoffman J; Callahan E; Price R; Cheng J; Cohen S; Lewis N; Watkins-Bruner D; Rogatko A; Konski A
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1389-93. PubMed ID: 17394942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase I study of capecitabine with concurrent radiotherapy in early-stage nasopharyngeal carcinoma].
    Guo L; Lin HX; Li FY; Li Q; Qiu F; Luo DH; Guo X; Hong MH
    Zhonghua Zhong Liu Za Zhi; 2004 Apr; 26(4):250-3. PubMed ID: 15312392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.
    Jansen EP; Boot H; Saunders MP; Crosby TD; Dubbelman R; Bartelink H; Verheij M; Cats A
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1424-8. PubMed ID: 17689023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer.
    Rödel C; Grabenbauer GG; Papadopoulos T; Hohenberger W; Schmoll HJ; Sauer R
    J Clin Oncol; 2003 Aug; 21(16):3098-104. PubMed ID: 12915600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.
    Souglakos J; Androulakis N; Mavroudis D; Kourousis C; Kakolyris S; Vardakis N; Kalbakis K; Pallis A; Ardavanis A; Varveris C; Georgoulias V
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1284-7. PubMed ID: 12873672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemoradiation for locally advanced rectal cancer with capecitabine 2,000 mg/m2/day.
    Veerasarn V; Boonnuch W; Chinswangwatanakul V; Lohsiriwat D; Mahamadsolaeh P
    J Med Assoc Thai; 2008 Oct; 91(10):1583-8. PubMed ID: 18972903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.
    Zampino MG; Magni E; Leonardi MC; Petazzi E; Santoro L; Luca F; Chiappa A; Petralia G; Trovato C; Fazio N; Orecchia R; Nolè F; de Braud F
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):421-7. PubMed ID: 19211200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.
    Akgun Z; Saglam S; Yucel S; Gural Z; Balik E; Cipe G; Yildiz S; Kilickap S; Okyar A; Kaytan-Saglam E
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):751-6. PubMed ID: 25102935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer: a phase II study.
    Bajetta E; Pietrantonio F; Buzzoni R; Ferrario E; Valvo F; Mariani L; Dotti KF; Biondani P; Formisano B; Gevorgyan A; Grassi P; Di Bartolomeo M
    Am J Clin Oncol; 2014 Dec; 37(6):545-9. PubMed ID: 23428953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.